Titan Pharmaceuticals Inc. (NASDAQ: TTNP) open the trading on September 10, 2020, with great promise as it jumped 0.25% to $0.20. During the day, the stock rose to $0.2098 and sunk to $0.20 before settling in for the price of $0.20 at the close. Taking a more long-term approach, TTNP posted a 52-week range of $0.14-$0.59.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -0.20%. Meanwhile, its Annual Earning per share during the time was 3.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.90%. This publicly-traded company’s shares outstanding now amounts to $95.66 million, simultaneously with a float of $95.38 million. The organization now has a market capitalization sitting at $21.01 million. At the time of writing, stock’s 50-day Moving Average stood at $0.2764, while the 200-day Moving Average is $0.2615.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 21 employees. It has generated 171,952 per worker during the last fiscal year. Meanwhile, its income per employee was -783,714. The stock had 2.55 Receivables turnover and 0.31 Total Asset turnover. For the Profitability, stocks gross margin was +64.33, operating margin was -466.46 and Pretax Margin of -455.77.
Titan Pharmaceuticals Inc. (TTNP) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Titan Pharmaceuticals Inc.’s current insider ownership accounts for 0.30%, in contrast to 6.10% institutional ownership.
Titan Pharmaceuticals Inc. (TTNP) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 6/29/2020 suggests? It has posted -$0.05 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.03) by -$0.02. This company achieved a net margin of -455.77 while generating a return on equity of -398.31. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
Titan Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 7.90% and is forecasted to reach -0.15 in the upcoming year.
Titan Pharmaceuticals Inc. (NASDAQ: TTNP) Trading Performance Indicators
Let’s observe the current performance indicators for Titan Pharmaceuticals Inc. (TTNP). It’s Quick Ratio in the last reported quarter now stands at 1.60. The Stock has managed to achieve an average true range (ATR) of 0.02. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.38.
In the same vein, TTNP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.38, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.15 at the market close of one year from today.
Technical Analysis of Titan Pharmaceuticals Inc. (TTNP)
[Titan Pharmaceuticals Inc., TTNP] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 42.18% While, its Average True Range was 0.0165.
Raw Stochastic average of Titan Pharmaceuticals Inc. (TTNP) in the period of the previous 100 days is set at 11.16%, which indicates a major fall in contrast to 36.31% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 68.42% that was lower than 112.07% volatility it exhibited in the past 100-days period.